Suppr超能文献

用于高通量生物医学筛选的微流控系统的制造与应用机制:综述

The Fabrication and Application Mechanism of Microfluidic Systems for High Throughput Biomedical Screening: A Review.

作者信息

Song Kena, Li Guoqiang, Zu Xiangyang, Du Zhe, Liu Liyu, Hu Zhigang

机构信息

College of Medical Technology and Engineering, Henan University of Science and Technology, He'nan 471023, China.

College of Physics, Chongqing University, Chongqing 401331, China.

出版信息

Micromachines (Basel). 2020 Mar 11;11(3):297. doi: 10.3390/mi11030297.

Abstract

Microfluidic systems have been widely explored based on microfluidic technology, and it has been widely used for biomedical screening. The key parts are the fabrication of the base scaffold, the construction of the matrix environment in the 3D system, and the application mechanism. In recent years, a variety of new materials have emerged, meanwhile, some new technologies have been developed. In this review, we highlight the properties of high throughput and the biomedical application of the microfluidic chip and focus on the recent progress of the fabrication and application mechanism. The emergence of various biocompatible materials has provided more available raw materials for microfluidic chips. The material is not confined to polydimethylsiloxane (PDMS) and the extracellular microenvironment is not limited by a natural matrix. The mechanism is also developed in diverse ways, including its special physical structure and external field effects, such as dielectrophoresis, magnetophoresis, and acoustophoresis. Furthermore, the cell/organ-based microfluidic system provides a new platform for drug screening due to imitating the anatomic and physiologic properties in vivo. Although microfluidic technology is currently mostly in the laboratory stage, it has great potential for commercial applications in the future.

摘要

基于微流控技术的微流控系统已得到广泛探索,并已广泛应用于生物医学筛选。关键部分包括基础支架的制造、三维系统中基质环境的构建以及应用机制。近年来,出现了各种新型材料,同时也开发了一些新技术。在本综述中,我们重点介绍了微流控芯片的高通量特性及其生物医学应用,并关注制造和应用机制的最新进展。各种生物相容性材料的出现为微流控芯片提供了更多可用的原材料。材料不限于聚二甲基硅氧烷(PDMS),细胞外微环境也不受天然基质的限制。其机制也以多种方式发展,包括其特殊的物理结构和外部场效应,如介电电泳、磁泳和声泳。此外,基于细胞/器官的微流控系统由于模拟了体内的解剖和生理特性,为药物筛选提供了一个新平台。尽管微流控技术目前大多处于实验室阶段,但未来具有巨大的商业应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98d8/7143183/b77e89a2892b/micromachines-11-00297-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验